chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Vaccine induced antibody absent, Viral titre decreased
Clinical narrative: the results came back not immune.; the results came back not immune.; the results came back not immune.; the results came back not immune.; This spontaneous report was received from a physician and refers to a 21-year-old female patient.  The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported.  On an unknown date, the patient started therapy with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (manufacturer unknown) injection,, administered for prophylaxis (strength, dose description, lot #, expiry date, and route of administration were not provided).  On 05-NOV-2009, the patient started therapy with varicella virus vaccine live (oka/merck) (manufacturer unknown) injection, unk, administered for prophylaxis (strength, lot #, expiry date, and route of administration were not provided).  On an unknown date, the patient had titers performed,  the results came back not immune. The outcome of the event the results came back not immune was unknown. She was administered measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II), varicella virus vaccine live (oka/merck) (VARIVAX) and had no adverse experience reported to our products.  The causal relationship between the events and suspect vaccines was not provided. No further information is available
Age: 60.0
Sex: F
Vaccine: MMR
Symptoms: Rash
Clinical narrative: Pharmacist reports an AE for MMRII stating a patient complains of rash on her legs after receiving MMRII vaccination on 4/19/2023; This spontaneous report has been received from a pharmacist referring to a 60-year-old female patient. The patient's pertinent medical history, concomitant therapy, and drug allergy or reaction were not provided.  On 19-APR-2023, the patient received Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II), therapy type rHA, 0.5 ml, subcutaneously (Quantity: 1) as prophylaxis (valid lot number: U039548, and the expiration date was reported on 14-DEC-2023).  On the same day, the patient complained of rash on her legs after receiving Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) vaccination. No additional information was provided. The patient had sought medical attention. The outcome of the event was not provided. The action taken was not applicable.  The relationship between the event and the vaccine was not provided.
Sex: U
Vaccine: MMR
Symptoms: Expired product administered, No adverse event
Clinical narrative: No additional AE; an expired MMR II was administered to a patient; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's medical history, historical drugs, past drug reactions or allergies, concurrent conditions, and concomitant drugs were not reported.   On 27-APR-2023, the patient was vaccinated with 1 dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) (lot#: u007685, expiration date: 09-MAR-2023; strength, route of administration, and anatomical location were not reported) for prophylaxis (expired product administered). The diluent was not expired. No additional adverse events (AE) were reported (no adverse event).
Sex: F
Vaccine: HPV9
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: No additional AE; Patient came in and received on 5/3/2023 GARDASIL 9.; This spontaneous report was received from a female patient with unknown age via medical assistant. The patient's concurrent conditions, concomitant medication and pertinent medical history was not reported. The patient had no underlying disease and no previous history of allergy to vaccines.  On an unknown date in 2013, the patient was vaccinated with the first dose and the second dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) (dose, lot #, expiration date, anatomical location and route were not provided) at age 15 for prophylaxis. On 03-MAY-2023, the patient was vaccinated with the third dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) (dose, lot #, expiration date, anatomical location and route were not provided) for prophylaxis (inappropriate schedule of product administration). No additional adverse event (AE) (no adverse event).
Age: 0.33
Sex: U
Vaccine: RV5, UNK
Symptoms: No adverse event, Product storage error
Clinical narrative: No additional AE; TE with MMR II, PROQUAD, VARIVAX, GARDASIL 9, ROTATEQ, VAQTA, VAXELIS PFS. VAXELIS PFS and ROTATEQ; This spontaneous report was received from an other health professional and refers to a 4-month-old patient. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.  On 08-MAY-2023, the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent (ROTATEQ), dose 2 ml, lot #1938977 was valid, expiration date established as 30-APR-2024 (formulation, anatomical location were not reported) for prophylaxis. On 08-MAY-2023, the patient was vaccinated diphtheria toxoid (+) hepatitis b virus vaccine rhbsag (yeast) (+) hib conj vaccine (ompc) (+) pertussis acellular 5-component vaccine (+) poliovirus vaccine inactivated (vero) (+) tetanus toxoid (VAXELIS), dose 0.5 ml, lot # U7296A , expiration date provided as 26-FEB-2025 (formulation, anatomical location were not reported) for prophylaxis. Before the administration, vaccines underwent temperature excursion (product storage error). No additional adverse events were reported (no adverse event).
Sex: M
Vaccine: COVID19
Symptoms: Acoustic stimulation tests, Body temperature, Cardiac function test, Fever neonatal, Foetal exposure during pregnancy
Clinical narrative: FEVER; PROBLEMS WITH BREATHING; SUSPECTED COVID-19; FOETAL EXPOSURE DURING PREGNANCY; This solicited pregnancy report received from a consumer concerned a male neonate of an unspecified race and ethnicity. The patient was enrolled in a non-company sponsored study. The patient's weight was 3.51 kilograms, and height was not reported. No concurrent conditions were reported. The patient's mother medical history included asthma and polycystic ovary syndrome, multigravida. Maternal obstetrical history included two previous pregnancies, one resulting in miscarriage/ spontaneous abortion in less than 20 weeks and one in a live baby. The mother had no history of tobacco, e-cigarette and recreational drug use, and alcohol use. Maternal first day of the last menstrual period (LMP) was calculated to be 16-FEB-2021. The estimated delivery date (EDD) was reported to be 23-NOV-2021. Type of pregnancy was reported as singleton. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, transplacental, batch number: 1805022 expiry: UNKNOWN) dose was not reported, 1 total administered on 13-MAR-2021 (at gestational age three weeks and four days) for covid-19 immunisation. Concomitant medications included minerals nos/vitamins nos.  On 13-MAR-2021, the patient experienced foetal exposure during pregnancy. The duration for the event, foetal exposure during pregnancy was 255 days. at gestational age of 40 weeks, the patient's mother delivered a live, full-term, male neonate vaginally. The patient's mother's spent three days in hospital for the delivery. On 23-NOV-2021, the baby was admitted in NICU for fever and problems with breathing.  On NOV-2021, Laboratory data included: Cardiac function test (not reported), and Hearing test (not reported).  On 09-FEB-2022, the patient developed symptoms of COVID-19 (suspected covid-19): cough and fever of 101 Fahrenheit. On FEB-2022, Laboratory data included: Body temperature (not reported). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever, and problems with breathing on 25-NOV-2021, suspected covid-19 on 23-FEB-2022, and foetal exposure during pregnancy on 23-NOV-2021. The reporter considered the causality between covid-19 vaccine ad26.cov2.s, and fever, and problems with breathing as not related. The reporter did not provide a causality assessment between covid-19 vaccine ad26.cov2.s, and suspected covid-19, and foetal exposure during pregnancy. Company causality between covid-19 vaccine ad26.cov2.s, and suspected covid-19, and foetal exposure during pregnancy was not related.  This report was serious (Hospitalization Caused / Prolonged). This parent/child case is linked to 20211109970.; Sender's Comments: V0: 20230520946-Fever (Fever neonatal), problems with breathing. The event shows an incompatible temporal relationship. Therefore, this event is considered inconsistent with vaccine administration.
Sex: M
Vaccine: COVID19
Symptoms: Neonatal dyspnoea, Suspected COVID-19
Clinical narrative: FEVER; PROBLEMS WITH BREATHING; SUSPECTED COVID-19; FOETAL EXPOSURE DURING PREGNANCY; This solicited pregnancy report received from a consumer concerned a male neonate of an unspecified race and ethnicity. The patient was enrolled in a non-company sponsored study. The patient's weight was 3.51 kilograms, and height was not reported. No concurrent conditions were reported. The patient's mother medical history included asthma and polycystic ovary syndrome, multigravida. Maternal obstetrical history included two previous pregnancies, one resulting in miscarriage/ spontaneous abortion in less than 20 weeks and one in a live baby. The mother had no history of tobacco, e-cigarette and recreational drug use, and alcohol use. Maternal first day of the last menstrual period (LMP) was calculated to be 16-FEB-2021. The estimated delivery date (EDD) was reported to be 23-NOV-2021. Type of pregnancy was reported as singleton. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, transplacental, batch number: 1805022 expiry: UNKNOWN) dose was not reported, 1 total administered on 13-MAR-2021 (at gestational age three weeks and four days) for covid-19 immunisation. Concomitant medications included minerals nos/vitamins nos.  On 13-MAR-2021, the patient experienced foetal exposure during pregnancy. The duration for the event, foetal exposure during pregnancy was 255 days. at gestational age of 40 weeks, the patient's mother delivered a live, full-term, male neonate vaginally. The patient's mother's spent three days in hospital for the delivery. On 23-NOV-2021, the baby was admitted in NICU for fever and problems with breathing.  On NOV-2021, Laboratory data included: Cardiac function test (not reported), and Hearing test (not reported).  On 09-FEB-2022, the patient developed symptoms of COVID-19 (suspected covid-19): cough and fever of 101 Fahrenheit. On FEB-2022, Laboratory data included: Body temperature (not reported). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever, and problems with breathing on 25-NOV-2021, suspected covid-19 on 23-FEB-2022, and foetal exposure during pregnancy on 23-NOV-2021. The reporter considered the causality between covid-19 vaccine ad26.cov2.s, and fever, and problems with breathing as not related. The reporter did not provide a causality assessment between covid-19 vaccine ad26.cov2.s, and suspected covid-19, and foetal exposure during pregnancy. Company causality between covid-19 vaccine ad26.cov2.s, and suspected covid-19, and foetal exposure during pregnancy was not related.  This report was serious (Hospitalization Caused / Prolonged). This parent/child case is linked to 20211109970.; Sender's Comments: V0: 20230520946-Fever (Fever neonatal), problems with breathing. The event shows an incompatible temporal relationship. Therefore, this event is considered inconsistent with vaccine administration.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray, Headache, Vaccination site pain
Clinical narrative: after all shots she had a sore left arm injection site; Light Headache; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PAIN (after all shots she had a sore left arm injection site) and HEADACHE (Light Headache) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 057M21A, 004F21A, 043L20A and 037K20A) for COVID-19 prophylaxis.     The patient's past medical history included COVID-19 on 06-Sep-2020, Pancreas disorder (resolved prior to vaccination) and Myocarditis (mild, after COVID disease). Previously administered products included for Product used for unknown indication: FLU shot. Past adverse reactions to the above products included No adverse event with FLU shot. Concurrent medical conditions included Osteoarthritis (10+years) and Hypothyroidism (10 years ago). Concomitant products included LEVOTHYROXINE for Hypothyroidism, ONDANSETRON (ZOFRAN [ONDANSETRON]), CHLORDIAZEPOXIDE HYDROCHLORIDE, CLIDINIUM BROMIDE (LIBRAX [CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE]) and PANTOPRAZOLE for an unknown indication.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Apr-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (after all shots she had a sore left arm injection site) and HEADACHE (Light Headache). At the time of the report, VACCINATION SITE PAIN (after all shots she had a sore left arm injection site) and HEADACHE (Light Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Chest X-ray: post COVID disease was normal.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient took Advil or Tylenol (Does not remember clearly).   This case was linked to US-MODERNATX, INC.-MOD-2023-723293 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-723293:(Bivalent Dose Case)
Age: 77.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site bruising, Injection site erythema, Injection site pain
Clinical narrative: Site: Bruising at Injection Site-Mild, Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Mild
Age: 29.0
Sex: F
Vaccine: TYP
Symptoms: Dizziness, Seizure, Syncope, Unresponsive to stimuli
Clinical narrative: Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Severe, Systemic: Seizure-Severe, Additional Details: LOC and vasovagal after vaccine administration. Tonic clonic movement to all extremities with head deviation to R. History of seizure after vaccine x1 in the past. EMS activated. Strongly advised patient to follow up in ER.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Asthenia, Erythema, Fatigue, Feeling hot, Flatulence
Clinical narrative: Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Systemic: Body Aches Generalized-Severe, Systemic: Exhaustion / Lethargy-Severe, Systemic: Nausea-Medium, Additional Details: pt state symptoms started about 4 hrs after vaccination. it started with swelling. and 6 hrs after pt reported having a loss of body strenght, body aches and nausea. after 48 hrs pt stated that majority of the symptoms have subsided, but on day 3 still gas some swelling (feels hot and is red) and the arm is still sore.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Lethargy, Nausea
Clinical narrative: Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Systemic: Body Aches Generalized-Severe, Systemic: Exhaustion / Lethargy-Severe, Systemic: Nausea-Medium, Additional Details: pt state symptoms started about 4 hrs after vaccination. it started with swelling. and 6 hrs after pt reported having a loss of body strenght, body aches and nausea. after 48 hrs pt stated that majority of the symptoms have subsided, but on day 3 still gas some swelling (feels hot and is red) and the arm is still sore.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Pain, Pain in extremity, Swelling
Clinical narrative: Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Systemic: Body Aches Generalized-Severe, Systemic: Exhaustion / Lethargy-Severe, Systemic: Nausea-Medium, Additional Details: pt state symptoms started about 4 hrs after vaccination. it started with swelling. and 6 hrs after pt reported having a loss of body strenght, body aches and nausea. after 48 hrs pt stated that majority of the symptoms have subsided, but on day 3 still gas some swelling (feels hot and is red) and the arm is still sore.
Age: 71.0
Sex: F
Vaccine: COVID19-2
Symptoms: Injection site erythema, Injection site pruritus
Clinical narrative: Site: Itching at Injection Site-Medium, Site: Redness at Injection Site-Medium
Age: 30.0
Sex: F
Vaccine: ANTH
Symptoms: Pruritus, Rash, Urticaria
Clinical narrative: HIVE LIKE RASH ON CHEST BACK AND ARMS, TOOK TWO BENADRYL, APPLIED HYDROCORTISONE CREAM FOR ITCHING AND WENT TO BED.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE  ACUTE RESPIRATORY FAILURE
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Urethral pain
Clinical narrative: Received a Pfizer Covid-19 covalent vaccination at 3:30 PM. A 9:00 PM I experience a sharp pain in the urethra of my penis. It was gone when I woke up the next morning.
Age: 66.0
Sex: F
Vaccine: COVID19, PPV
Symptoms: Headache, Hypotension, Hypothermia, Injection site erythema, Injection site pain
Clinical narrative: COVID-19 bivalent booster vaccine use for COVID-19 under Emergency Use Authorization (EUA): Patient received Pneumovax and COVID booster in the same arm on 5/5/23; Presented to ED 5/7/23 for headache and pain/redness at injection site; patient developed hypotension, requiring a short course of vasopressors; patient also developed hypothermia; admitted for suspected myositis
Age: 66.0
Sex: F
Vaccine: COVID19, PPV
Symptoms: Myositis
Clinical narrative: COVID-19 bivalent booster vaccine use for COVID-19 under Emergency Use Authorization (EUA): Patient received Pneumovax and COVID booster in the same arm on 5/5/23; Presented to ED 5/7/23 for headache and pain/redness at injection site; patient developed hypotension, requiring a short course of vasopressors; patient also developed hypothermia; admitted for suspected myositis
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Hypotension
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE HYPOTENSION
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Hypotension
Clinical narrative: HYPOTENSION
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chills, Diarrhoea, Nausea, SARS-CoV-2 test positive
Clinical narrative: 03/31/23 presents to ED for "chills" "NVD". PMHx of "DM" "morbid obesity"
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: 03/31/23 presents to ED for "chills" "NVD". PMHx of "DM" "morbid obesity"
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Respiratory failure
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE  ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Respiratory distress, SARS-CoV-2 test positive
Clinical narrative: 04/01/23 presents to EC ED for "respiratory distress". PMHx of "DM, HTN, OSA, asthma, COPD"
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Deep vein thrombosis, Pulmonary embolism
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE  ACUTE DVT OF LEFT LEG, UNSPECIFIED VEIN PULMONARY EMBOLISM, UNSPECIFIED.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Coagulopathy, Neuropathy peripheral
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE  COAGULOPATHY, UNSPECIFIED TYPE PERIPHERAL NEUROPATHY
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: 04/01/23 presents to ED for "breathing problem". PMHx of "hypertension, hyperlipidemia, CHF, BPH"
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Hypoxia
Clinical narrative: ACUTE HYPOXEMIC RESPIRATORY FAILURE HYPOXIA
Age: 86.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Cough, Fall, Fatigue, SARS-CoV-2 test positive
Clinical narrative: 04/03/23 presents to ED for "fatigue, falls, cough". PMHx of "Waldenstrom's macroglobulinemia, SIADH, atrial fibrillation, and obstructive sleep apnea"
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Hypoxia
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE HYPOXEMIC RESPIRATORY FAILURE HYPOXIA
Age: 77.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, Anticoagulant therapy, Anxiety, Arthropathy, Atrial fibrillation
Clinical narrative: Discharge Provider: DO Primary Care Provider at Discharge: DO Admission Date: 5/8/2023 Discharge Date: 05/10/2023  Discharge Disposition:  Home   DISCHARGE DIAGNOSIS: 1. Severe COVID-19 infection with acute hypoxic respiratory failure 2. Permanent AFib status post ablation 2019 and Watchman 2023 3. Chronic diastolic CHF 4. Hypertension 5. Dyslipidemia 6. Coronary artery disease in right coronary artery 7. History of stroke 8. Venous insufficiency 9. History of cancer 10. Neuropathy 11. Anxiety 12. Obesity  PRESENTING PROBLEM: Severe COVID-19 infection with acute hypoxic respiratory failure   HOSPITAL COURSE: Patient was admitted to the hospital on 05/08/2023 with reports of fatigue for the past 6 weeks knee and shortness of breath since 05/05/2023.  She has a history of diastolic CHF, permanent Afib, and history of stroke.  She is currently anticoagulated with warfarin, aspirin, and Plavix.  She was tested for COVID and was found to be positive on 05/08 she was given dose of Solu-Medrol and was begun on remdesivir.  Her oxygen saturation dropped to 84% with ambulation, but she was able to improved to greater than 90% on room air with rest.  PT and OT screen the patient and reported that she was independent with all mobility and did not need skilled PT or OT at this time.  She was continued with oral Decadron as well as Mucinex and Tessalon.  Her CMP was monitored throughout her hospital stay and were grossly within normal limits.  Her CRP improved from 11.4 to 4.6.  She reported improvement with her symptoms after 3 days of remdesivir.  She had no further concerns, and was discharged home in improved in stable condition
Age: 77.0
Sex: F
Vaccine: COVID19-2
Symptoms: C-reactive protein increased, COVID-19, Cardiac failure congestive, Chronic left ventricular failure, Condition aggravated
Clinical narrative: Discharge Provider: DO Primary Care Provider at Discharge: DO Admission Date: 5/8/2023 Discharge Date: 05/10/2023  Discharge Disposition:  Home   DISCHARGE DIAGNOSIS: 1. Severe COVID-19 infection with acute hypoxic respiratory failure 2. Permanent AFib status post ablation 2019 and Watchman 2023 3. Chronic diastolic CHF 4. Hypertension 5. Dyslipidemia 6. Coronary artery disease in right coronary artery 7. History of stroke 8. Venous insufficiency 9. History of cancer 10. Neuropathy 11. Anxiety 12. Obesity  PRESENTING PROBLEM: Severe COVID-19 infection with acute hypoxic respiratory failure   HOSPITAL COURSE: Patient was admitted to the hospital on 05/08/2023 with reports of fatigue for the past 6 weeks knee and shortness of breath since 05/05/2023.  She has a history of diastolic CHF, permanent Afib, and history of stroke.  She is currently anticoagulated with warfarin, aspirin, and Plavix.  She was tested for COVID and was found to be positive on 05/08 she was given dose of Solu-Medrol and was begun on remdesivir.  Her oxygen saturation dropped to 84% with ambulation, but she was able to improved to greater than 90% on room air with rest.  PT and OT screen the patient and reported that she was independent with all mobility and did not need skilled PT or OT at this time.  She was continued with oral Decadron as well as Mucinex and Tessalon.  Her CMP was monitored throughout her hospital stay and were grossly within normal limits.  Her CRP improved from 11.4 to 4.6.  She reported improvement with her symptoms after 3 days of remdesivir.  She had no further concerns, and was discharged home in improved in stable condition
Age: 77.0
Sex: F
Vaccine: COVID19-2
Symptoms: Coronary artery disease, Dyslipidaemia, Dyspnoea, Fatigue, Hypertension
Clinical narrative: Discharge Provider: DO Primary Care Provider at Discharge: DO Admission Date: 5/8/2023 Discharge Date: 05/10/2023  Discharge Disposition:  Home   DISCHARGE DIAGNOSIS: 1. Severe COVID-19 infection with acute hypoxic respiratory failure 2. Permanent AFib status post ablation 2019 and Watchman 2023 3. Chronic diastolic CHF 4. Hypertension 5. Dyslipidemia 6. Coronary artery disease in right coronary artery 7. History of stroke 8. Venous insufficiency 9. History of cancer 10. Neuropathy 11. Anxiety 12. Obesity  PRESENTING PROBLEM: Severe COVID-19 infection with acute hypoxic respiratory failure   HOSPITAL COURSE: Patient was admitted to the hospital on 05/08/2023 with reports of fatigue for the past 6 weeks knee and shortness of breath since 05/05/2023.  She has a history of diastolic CHF, permanent Afib, and history of stroke.  She is currently anticoagulated with warfarin, aspirin, and Plavix.  She was tested for COVID and was found to be positive on 05/08 she was given dose of Solu-Medrol and was begun on remdesivir.  Her oxygen saturation dropped to 84% with ambulation, but she was able to improved to greater than 90% on room air with rest.  PT and OT screen the patient and reported that she was independent with all mobility and did not need skilled PT or OT at this time.  She was continued with oral Decadron as well as Mucinex and Tessalon.  Her CMP was monitored throughout her hospital stay and were grossly within normal limits.  Her CRP improved from 11.4 to 4.6.  She reported improvement with her symptoms after 3 days of remdesivir.  She had no further concerns, and was discharged home in improved in stable condition
Age: 77.0
Sex: F
Vaccine: COVID19-2
Symptoms: Left atrial appendage closure implant, Metabolic function test normal, Neuropathy peripheral, Obesity, Oxygen saturation decreased
Clinical narrative: Discharge Provider: DO Primary Care Provider at Discharge: DO Admission Date: 5/8/2023 Discharge Date: 05/10/2023  Discharge Disposition:  Home   DISCHARGE DIAGNOSIS: 1. Severe COVID-19 infection with acute hypoxic respiratory failure 2. Permanent AFib status post ablation 2019 and Watchman 2023 3. Chronic diastolic CHF 4. Hypertension 5. Dyslipidemia 6. Coronary artery disease in right coronary artery 7. History of stroke 8. Venous insufficiency 9. History of cancer 10. Neuropathy 11. Anxiety 12. Obesity  PRESENTING PROBLEM: Severe COVID-19 infection with acute hypoxic respiratory failure   HOSPITAL COURSE: Patient was admitted to the hospital on 05/08/2023 with reports of fatigue for the past 6 weeks knee and shortness of breath since 05/05/2023.  She has a history of diastolic CHF, permanent Afib, and history of stroke.  She is currently anticoagulated with warfarin, aspirin, and Plavix.  She was tested for COVID and was found to be positive on 05/08 she was given dose of Solu-Medrol and was begun on remdesivir.  Her oxygen saturation dropped to 84% with ambulation, but she was able to improved to greater than 90% on room air with rest.  PT and OT screen the patient and reported that she was independent with all mobility and did not need skilled PT or OT at this time.  She was continued with oral Decadron as well as Mucinex and Tessalon.  Her CMP was monitored throughout her hospital stay and were grossly within normal limits.  Her CRP improved from 11.4 to 4.6.  She reported improvement with her symptoms after 3 days of remdesivir.  She had no further concerns, and was discharged home in improved in stable condition
Age: 77.0
Sex: F
Vaccine: COVID19-2
Symptoms: Peripheral venous disease, SARS-CoV-2 test positive
Clinical narrative: Discharge Provider: DO Primary Care Provider at Discharge: DO Admission Date: 5/8/2023 Discharge Date: 05/10/2023  Discharge Disposition:  Home   DISCHARGE DIAGNOSIS: 1. Severe COVID-19 infection with acute hypoxic respiratory failure 2. Permanent AFib status post ablation 2019 and Watchman 2023 3. Chronic diastolic CHF 4. Hypertension 5. Dyslipidemia 6. Coronary artery disease in right coronary artery 7. History of stroke 8. Venous insufficiency 9. History of cancer 10. Neuropathy 11. Anxiety 12. Obesity  PRESENTING PROBLEM: Severe COVID-19 infection with acute hypoxic respiratory failure   HOSPITAL COURSE: Patient was admitted to the hospital on 05/08/2023 with reports of fatigue for the past 6 weeks knee and shortness of breath since 05/05/2023.  She has a history of diastolic CHF, permanent Afib, and history of stroke.  She is currently anticoagulated with warfarin, aspirin, and Plavix.  She was tested for COVID and was found to be positive on 05/08 she was given dose of Solu-Medrol and was begun on remdesivir.  Her oxygen saturation dropped to 84% with ambulation, but she was able to improved to greater than 90% on room air with rest.  PT and OT screen the patient and reported that she was independent with all mobility and did not need skilled PT or OT at this time.  She was continued with oral Decadron as well as Mucinex and Tessalon.  Her CMP was monitored throughout her hospital stay and were grossly within normal limits.  Her CRP improved from 11.4 to 4.6.  She reported improvement with her symptoms after 3 days of remdesivir.  She had no further concerns, and was discharged home in improved in stable condition
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Back pain, Balance disorder, Blood test, Brain fog
Clinical narrative: Brain fog along with cognitive issues also Blurry vision. Right leg tremors which now has progressed to whole body tremors. Right hip pain sever and mild left side hip pain. Hand swelling along with neck and back pain which has professed to joint pain threw out body . Right sided weakness and lose of balance. Sleeping issues .
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Cognitive disorder, Hemiparesis, Lumbar puncture, Magnetic resonance imaging head abnormal, Magnetic resonance imaging neck
Clinical narrative: Brain fog along with cognitive issues also Blurry vision. Right leg tremors which now has progressed to whole body tremors. Right hip pain sever and mild left side hip pain. Hand swelling along with neck and back pain which has professed to joint pain threw out body . Right sided weakness and lose of balance. Sleeping issues .
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Magnetic resonance imaging spinal, Neck pain, Peripheral swelling, Sleep disorder, Tremor
Clinical narrative: Brain fog along with cognitive issues also Blurry vision. Right leg tremors which now has progressed to whole body tremors. Right hip pain sever and mild left side hip pain. Hand swelling along with neck and back pain which has professed to joint pain threw out body . Right sided weakness and lose of balance. Sleeping issues .
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Vision blurred, X-ray
Clinical narrative: Brain fog along with cognitive issues also Blurry vision. Right leg tremors which now has progressed to whole body tremors. Right hip pain sever and mild left side hip pain. Hand swelling along with neck and back pain which has professed to joint pain threw out body . Right sided weakness and lose of balance. Sleeping issues .
Age: 5.0
Sex: F
Vaccine: RV5
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Pt was  given this Imm after the age limit. Pt's mother asked for that Imm and the provider ordered it.  No adverse reaction happened, Imm was given after age limit.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Bell's palsy, Ear pain, Headache, Pain in jaw, Tinnitus
Clinical narrative: Bell's Palsy, left ear pain, left jaw pain, sharp headache, rings in ears (both sides)
Age: 74.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Cough, Headache, Malaise, Rhinorrhoea
Clinical narrative: I had a headache the evening after receiving the vaccine that lasted one day. I started feeling ill on 05/06/2023 with a dry cough, scratchy throat and runny nose. I tested positive for COVID-19 on 05/08/2023. I had a telehealth visit with a provider and got prescription for Paxlovid. I am tolerating the medication without any complications.
Age: 74.0
Sex: M
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test positive, Throat irritation
Clinical narrative: I had a headache the evening after receiving the vaccine that lasted one day. I started feeling ill on 05/06/2023 with a dry cough, scratchy throat and runny nose. I tested positive for COVID-19 on 05/08/2023. I had a telehealth visit with a provider and got prescription for Paxlovid. I am tolerating the medication without any complications.
Age: 17.0
Sex: F
Vaccine: MNQ
Symptoms: Product preparation error
Clinical narrative: Vaccine powder was incorrectly mixed with sterile diluent instead of diluent included in box.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea, Fatigue, SARS-CoV-2 test positive
Clinical narrative: 04/03/23 presents to ED for "fatigue, SOB". PMHx of "asthma and bronchitis"
Age: 0.92
Sex: F
Vaccine: HEPA
Symptoms: Incorrect dose administered
Clinical narrative: I GAVE AN ADULT DOSE OF HEP A TO THE CHILD.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE ST ELEVATION MI, INFERIOR WALL ACUTE NON ST ELEVATION MI
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Deep vein thrombosis, Pulmonary embolism, Symptom recurrence
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE MULTIPLE SUBSEGMENTAL PULMONARY EMBOLI WITHOUT ACUTE COR PULMONALE ACUTE DVT OF LEFT LEG, UNSPECIFIED VEIN 8/12/2022,  9/13/2022,  10/7/2022,  1/7/2023 -- RECURRENCE OF SAME SYMPTOMS
Age: 63.0
Sex: F
Vaccine: MMRV
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Patient is an adult and received the MMRV vaccine. No treatment needed and no adverse reaction occurred.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Appendicectomy
Clinical narrative: Emergency appendectomy
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ALLERGIC REACTION, INIT
Age: 75.0
Sex: M
Vaccine: COVID19-2
Symptoms: Chemotherapy, Non-Hodgkin's lymphoma, Pain in extremity, Radiotherapy
Clinical narrative: I had mild soreness in my arm after receiving the vaccine for a couple of days. I was diagnosed with Non-Hodgkins Lymphoma in 11/2022.  I am receiving chemotherapy and I have completed radiation.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure
Clinical narrative: ACUTE HYPOXEMIC RESPIRATORY FAILURE
Age: 71.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: COVID-19, Cough, Fatigue, Headache, Lethargy
Clinical narrative: I had a really bad headache, coughing some achiness that started on the late April 14, 2023. The next day I was feeling worse, I got a fever, I used a home COVID-19 test that came back positive. I called my doctor to let her know I had tested positive and discuss my symptoms. I was prescribed Lagevrio, I started taking the medication immediately. Once I finished the medication, I felt lethargic and fatigued, I still have a stuffy head.
Age: 71.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: Pain, Pyrexia, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: I had a really bad headache, coughing some achiness that started on the late April 14, 2023. The next day I was feeling worse, I got a fever, I used a home COVID-19 test that came back positive. I called my doctor to let her know I had tested positive and discuss my symptoms. I was prescribed Lagevrio, I started taking the medication immediately. Once I finished the medication, I felt lethargic and fatigued, I still have a stuffy head.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity, Partial seizures, Petit mal epilepsy
Clinical narrative: PARTIAL EPILEPSY ABSENCE EPILEPSY ALLERGIC REACTION, INIT
Age: 65.0
Sex: M
Vaccine: COVID19-2
Symptoms: Product storage error
Clinical narrative: PATIENT RECEIVED VACCINE THAT WAS OUT OF RANGE OF THE STORAGE CRITERIA. NO STABILITY INFORMATION AVAILABLE TO DETERMINE THE VALIDITY OF THE VACCINE ADMINISTERED.
Age: 92.0
Sex: M
Vaccine: COVID19
Symptoms: Coagulopathy, Diabetic nephropathy
Clinical narrative: D68.9 COAGULOPATHY, UNSPECIFIED TYPE 2/23/2022 DM 2 W RENAL MANIFESTATION
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Obstructive sleep apnoea syndrome
Clinical narrative: OBSTRUCTIVE SLEEP APNEA
Age: 32.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Abdominal pain upper, Autonomic nervous system imbalance, Cholinergic syndrome, Chronic fatigue syndrome, Computerised tomogram normal
Clinical narrative: Headache, diarrhea, and stomach ache 6 days after first COVID vaccine dose. Received second dose 3 weeks later in May 2021 as per recommendations at that time. Received monovalent purple cap booster dose in December 2021.  Symptoms progressed over the rest of 2021 to chronic daily headache while awake (by December 2021), orthostatic intolerance with dizziness (by June 2021), heat intolerance (by June 2021), and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). All symptoms have continued to present time.
Age: 32.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Diarrhoea, Dizziness, Ganglioneuroma, Headache, Laboratory test normal
Clinical narrative: Headache, diarrhea, and stomach ache 6 days after first COVID vaccine dose. Received second dose 3 weeks later in May 2021 as per recommendations at that time. Received monovalent purple cap booster dose in December 2021.  Symptoms progressed over the rest of 2021 to chronic daily headache while awake (by December 2021), orthostatic intolerance with dizziness (by June 2021), heat intolerance (by June 2021), and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). All symptoms have continued to present time.
Age: 32.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Magnetic resonance imaging normal, Orthostatic intolerance, Peripheral nervous system function test abnormal, Post viral fatigue syndrome, Reflex test normal
Clinical narrative: Headache, diarrhea, and stomach ache 6 days after first COVID vaccine dose. Received second dose 3 weeks later in May 2021 as per recommendations at that time. Received monovalent purple cap booster dose in December 2021.  Symptoms progressed over the rest of 2021 to chronic daily headache while awake (by December 2021), orthostatic intolerance with dizziness (by June 2021), heat intolerance (by June 2021), and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). All symptoms have continued to present time.
Age: 32.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Temperature intolerance
Clinical narrative: Headache, diarrhea, and stomach ache 6 days after first COVID vaccine dose. Received second dose 3 weeks later in May 2021 as per recommendations at that time. Received monovalent purple cap booster dose in December 2021.  Symptoms progressed over the rest of 2021 to chronic daily headache while awake (by December 2021), orthostatic intolerance with dizziness (by June 2021), heat intolerance (by June 2021), and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). All symptoms have continued to present time.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Chronic obstructive pulmonary disease, Epilepsy, Left ventricular failure, Leukocytosis
Clinical narrative: EPILEPSY, UNSPECIFIED 6/14/2022 COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE)  ACUTE RESPIRATORY FAILURE 7/29/2022 COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE)  EPILEPSY, UNSPECIFIED 6/14/2022 ALTERED MENTAL STATUS, UNSPECIFIED  ACUTE RESPIRATORY FAILURE 7/29/2022 ALTERED MENTAL STATUS, UNSPECIFIED  EPILEPSY, UNSPECIFIED 6/14/2022 COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE)  ACUTE RESPIRATORY FAILURE 7/29/2022 COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE)  EPILEPSY, UNSPECIFIED 6/14/2022 SEPTIC SHOCK  ACUTE RESPIRATORY FAILURE 7/29/2022 SEPTIC SHOCK  EPILEPSY, UNSPECIFIED 6/14/2022 LEFT HEART FAILURE  ACUTE RESPIRATORY FAILURE 7/29/2022 LEFT HEART FAILURE  EPILEPSY, UNSPECIFIED 6/14/2022 LEUKOCYTOSIS  ACUTE RESPIRATORY FAILURE 7/29/2022 LEUKOCYTOSIS
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Mental status changes, Septic shock
Clinical narrative: EPILEPSY, UNSPECIFIED 6/14/2022 COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE)  ACUTE RESPIRATORY FAILURE 7/29/2022 COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE)  EPILEPSY, UNSPECIFIED 6/14/2022 ALTERED MENTAL STATUS, UNSPECIFIED  ACUTE RESPIRATORY FAILURE 7/29/2022 ALTERED MENTAL STATUS, UNSPECIFIED  EPILEPSY, UNSPECIFIED 6/14/2022 COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE)  ACUTE RESPIRATORY FAILURE 7/29/2022 COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE)  EPILEPSY, UNSPECIFIED 6/14/2022 SEPTIC SHOCK  ACUTE RESPIRATORY FAILURE 7/29/2022 SEPTIC SHOCK  EPILEPSY, UNSPECIFIED 6/14/2022 LEFT HEART FAILURE  ACUTE RESPIRATORY FAILURE 7/29/2022 LEFT HEART FAILURE  EPILEPSY, UNSPECIFIED 6/14/2022 LEUKOCYTOSIS  ACUTE RESPIRATORY FAILURE 7/29/2022 LEUKOCYTOSIS
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure
Clinical narrative: ACUTE RESPIRATORY FAILURE
Age: 70.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Fatigue, Hypersomnia, Pain, Pyrexia
Clinical narrative: 2/11/23 I had a fever around 100, achy feeling and very tired.  I took an at home COVID test which was positive.  My doctor prescribed Paxlovid which I started taking that day.  By day three, I was feeling much better. I slept a lot.  On 2/19/23, I had a bad runny nose and sneezing. On 2/20/23, I had a low-grade temperature and tested positive for COVID. This lasted about 24 hours
Age: 70.0
Sex: F
Vaccine: COVID19-2
Symptoms: Rhinorrhoea, SARS-CoV-2 test positive, Sneezing
Clinical narrative: 2/11/23 I had a fever around 100, achy feeling and very tired.  I took an at home COVID test which was positive.  My doctor prescribed Paxlovid which I started taking that day.  By day three, I was feeling much better. I slept a lot.  On 2/19/23, I had a bad runny nose and sneezing. On 2/20/23, I had a low-grade temperature and tested positive for COVID. This lasted about 24 hours
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Fatigue, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: I tested positive for COVID-19 on March 10, 2023 I experienced really bad cough, fever, fatigue, I was prescribed Paxlovid and cough suppressant for my symptoms.
Age: 64.0
Sex: F
Vaccine: COVID19-2
Symptoms: Blood test, COVID-19, Chest pain, Cough, Dyspnoea
Clinical narrative: I had a breakthrough Case of Covid-19 I had a cough that proceeded to worse after dose 5, I had trouble breathing, with chest pain and weasing. I was prescribed antibiotics
Age: 64.0
Sex: F
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test positive, Vaccine breakthrough infection, Wheezing
Clinical narrative: I had a breakthrough Case of Covid-19 I had a cough that proceeded to worse after dose 5, I had trouble breathing, with chest pain and weasing. I was prescribed antibiotics
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Femoral neck fracture, Postoperative wound infection
Clinical narrative: ACUTE RESPIRATORY FAILURE 9/25/2022 LEFT FEMORAL NECK UNSPECIFIED TYPE FX, INIT  ACUTE RESPIRATORY FAILURE 9/25/2022 POSTPROCEDURAL DEEP INCISIONAL WOUND INFECTION, SUBSEQ
Age: 28.0
Sex: F
Vaccine: COVID19-2
Symptoms: Abnormal dreams, Advanced sleep phase, Delusion, Sensory disturbance, Sleep study
Clinical narrative: They start to talk to you and it can't be heard by anyone else. I had weird dreams of herd immunity and people beating me to death. I dream in 54% REM, so I sleep longer in a deep sleep and at an elevated dream level. They are making contact somehow and I believe the vaccination is allowing them to take it a step further. On top of affecting my dreams, they have started to move something around in my body. They can make my skull vibrate now if I think of a thought. I'm sure it is top secret. THEY ARE KILLING PEOPLE.
Age: 8.0
Sex: F
Vaccine: HEPA
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Hepatitis A vaccine administered on wrong schedule: 1st dose on 3/29/23 and 2nd dose on 5/2/2023
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Hypotension, Metabolic encephalopathy
Clinical narrative: HYPOTENSION 3/30/2022 HX OF PULMONARY EMBOLUS  HYPOTENSION 3/30/2022 METABOLIC ENCEPHALOPATHY
Age: 54.0
Sex: M
Vaccine: COVID19-2
Symptoms: Product storage error
Clinical narrative: Patient received vaccine that fell out of stability storage range.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Hypotension
Clinical narrative: HYPOTENSION
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Pleural effusion
Clinical narrative: J96.00 ACUTE RESPIRATORY FAILURE 1/22/2022 PLEURAL EFFUSION J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 1/23/2022 PLEURAL EFFUSION
Age: 79.0
Sex: F
Vaccine: COVID19-2
Symptoms: Computerised tomogram head normal, Computerised tomogram neck, Headache, Neck pain, Neuralgia
Clinical narrative: I started having headaches in lower part of my head that radiated into my neck. It felt like a nerve spasm that was very painful. I made an appointment with my doctor when the headaches would not go away after a few days. My doctor ordered a CT scan, that did not reveal anything. My doctor prescribed Tramadol and Metaxalone to help with the pain. Today is the first day I have not had any pain.
Age: 79.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pain
Clinical narrative: I started having headaches in lower part of my head that radiated into my neck. It felt like a nerve spasm that was very painful. I made an appointment with my doctor when the headaches would not go away after a few days. My doctor ordered a CT scan, that did not reveal anything. My doctor prescribed Tramadol and Metaxalone to help with the pain. Today is the first day I have not had any pain.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Angioedema, Epilepsy
Clinical narrative: EPILEPSY, UNSPECIFIED ANGIOEDEMA, INIT
Age: 13.0
Sex: M
Vaccine: HPV9
Symptoms: Dizziness, Malaise, Nausea
Clinical narrative: I initially gave the vaccine after giving the VIS sheet. The vaccine was tolerated at the time of the shot. I then left the room. As the family was checking out, the PSS noticed he wasn't feeling too well, so a Medical Assistant and a Nurse Practitioner led the patient back to a room. He reported he was feeling dizzy and light headed and said he had nausea. He was told to lay down, was given apple juice, and a cold pack was placed on his neck . RN monitored him until he started to feel better after about 20 minutes later. No other symptoms were reported.
Age: 38.0
Sex: F
Vaccine: COVID19-2
Symptoms: Product storage error
Clinical narrative: Patient received vaccine that was out of storage stability range
Age: 2.0
Sex: M
Vaccine: MMRV
Symptoms: Contraindication to vaccination, No adverse event
Clinical narrative: Patient received MMRV live vaccine while taking sirolimus (immunosuppressant), which is contraindicated. Sirolimus stopped for 1-2 weeks after vaccination administered on 5/3/23 and patient being monitored for reaction. No reaction reported as of 5/7/23.
Age: 0.75
Sex: M
Vaccine: DTPPVHBHPB, PNC13, DTPPVHBHPB, PNC13
Symptoms: Diarrhoea, Vomiting
Clinical narrative: Currently having diarrhea over ten times a day, vomiting
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoxia, Pulmonary mass
Clinical narrative: HYPOXIA 1/22/2022 LUNG MASS
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Angina pectoris, Coronary artery disease
Clinical narrative: I20.9 ANGINA, UNSPECIFIED 3/22/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Obstructive sleep apnoea syndrome, Symptom recurrence
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE  ADULT OBSTRUCTIVE SLEEP APNEA, SEVERE 8/22/2022,  9/5/2022,  9/20/2022,  10/3/2022,  10/18/2022,  10/24/2022 -- RECURRENCE OF SAME SYMPTOMS